| Bioactivity | HPK1-IN-32 is a potent and selective HPK1 inhibitor with an IC50 of 65 nM. HPK1-IN-32 can be used for the research of HPK1 related disorders or diseases[1]. | ||||||||||||
| Invitro | HPK1-IN-32 (Example A34, 0-2 μM, 2 h) 抑制 Jurkat 细胞内 pSLP76 活性，IC50 为 65 nM[1]。 | ||||||||||||
| Name | HPK1-IN-32 | ||||||||||||
| CAS | 2766481-17-6 | ||||||||||||
| Formula | C28H37FN8O2 | ||||||||||||
| Molar Mass | 536.64 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Sanjia XU, et al. 3-[(1h-pyrazol-4-yl)oxy]pyrazin-2-amine compounds as hpk1 inhibitor and use thereof. Patent. WO2022068848. |
HPK1-IN-32
CAS: 2766481-17-6 F: C28H37FN8O2 W: 536.64
HPK1-IN-32 is a potent and selective HPK1 inhibitor with an IC50 of 65 nM. HPK1-IN-32 can be used for the research of HP
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.